Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P5CM
|
||||
Former ID |
DIB006751
|
||||
Drug Name |
AZD-3161
|
||||
Indication | Peripheral neuropathy [ICD10:G64] | Phase 1 | [549173] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Modulator | [551649] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.